Application of Immunoenhancing Radiotherapy in Treating Unresectable Intrahepatic Cholangiocarcinoma: A Case Report
Journal Title: Diseases & Research - Year 2024, Vol 4, Issue 1
Abstract
Unresectable intrahepatic cholangiocarcinoma currently lacks standard treatment methods. This report presents a case where PET/CT scans showed a subcapsular mass in the right posterior lobe of the liver measuring 6.2 cm × 3.7 cm × 3.8 cm, and a soft tissue nodule in the apicoposterior segment of the left upper lung lobe measuring 1.2 cm × 1.3 cm × 1.4 cm, both exhibiting increased glucose metabolism. A biopsy of the liver lesion confirmed well-differentiated cholangiocarcinoma, classified as Stage IV (cT1bN0M1). The patient, supported by their family, declined chemotherapy, surgery, immune checkpoint inhibitor therapy, and targeted therapy. Following a multidisciplinary team discussion, the patient was treated with conformal intensity-modulated radiotherapy aimed at the hepatic lesion, delivering a total dose of 50 Gy in ten sessions (5 Gy per session, once daily, five times per week). This was combined with 300 µg of granulocyte-macrophage colony-stimulating factor (GM-CSF), subcutaneously injected daily from the first to the tenth day of radiotherapy. No subsequent treatments were administered; only follow-up evaluations were performed. MRI assessments at three, twelve-, and twenty-four months post-treatment showed progressive reduction in the size of the hepatic primary lesion, with decreases of 15%, 36%, and 53% from baseline, respectively, and no growth in the pulmonary lesion. This outcome suggests that radiotherapy paired with an immunoadjuvant could be a viable treatment alternative for patients with unresectable intrahepatic cholangiocarcinoma.
Authors and Affiliations
Peng Jiang, Yingqi Zhang, Chenxing Shang, Jun Lu
Keywords
Related Articles
- EP ID EP740228
- DOI 10.54457/DR.202401006
- Views 27
- Downloads 1
Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma: A Report of 2 Cases and Literature Review
Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is indolent and progresses more slowly than other malignant lymphomas. The clinical features are not specific and the diagnosis can often be difficult. Here, we...
A Commentary on the Natural Disease Progression Sequence of Chronic Hepatitis B
Hepatitis B virus (HBV), an ancient family of hepatotropic DNA viruses with origins dating back millions of years, remains a major burden to human health today, although hepatitis B vaccines have dramatically reduced the...
Effect of Comparison between Qingchangligan Granules and Qingchangligan Decoction on D-GalN/LPS-Induced Liver Injury in Mice
Ethnopharmacological relevance The Qingchangligan formula has two dosage forms, granules and decoction. Both of them have the same prescription; however, whether their protective effects are different remain elusive. Ai...
Update Review of the Relationship Between Gut Microbiota and Neurodegenerative Diseases
Neurodegenerative disease is characterized by progressive deterioration of function or structure of nerve cells in central nervous system, mainly manifested as declined cognitive function and impaired motor behavior. Its...
Oral Versus Intravenous Chemotherapy in COVID-19 Epidemic
The novel coronavirus has a significant impact on the routine clinical practice for cancer patients in China since De-cember 2019. During the epidemic in mainland China, especially Wuhan, the intravenous chemotherapies o...